Custom CRISPR/Cas9-based multi-gene knockout in Bacillus subtilis for metabolic engineering and industrial strain development.
We design and deliver engineered B. subtilis strains with precise multi-gene deletions for metabolic pathway optimization and strain improvement.
Leveraging CRISPR/Cas9 technology for efficient and stable gene deletions in B. subtilis, a key industrial host.
In silico guide RNA design for each target locus, with off-target evaluation using proprietary algorithms. We validate targeting efficiency before proceeding.
For multi-gene knockouts, we employ a sequential strategy to introduce deletions one by one, with genotyping at each step.
B. subtilis is widely used for enzyme and metabolite production, making it a useful chassis for strain engineering; food-use safety status depends on the strain, product, and intended use.
Projects scoped from single to multiple gene knockouts, up to project-defined number.
Each knockout confirmed by PCR and Sanger sequencing; strain purity verified.
Final engineered strains and supporting documentation.
Each project is individually scoped based on target genes and project-scoped attributes assessed analytically.
| Parameter | Typical project scope |
|---|---|
| Number of target genes | Scoped per project, typical range 1–5; larger sets by consultation |
| Editing modality | Knockout (primary); knock-in/point mutation available on request |
| Host strain | Wild-type or specified B. subtilis strain (e.g., 168, WB800) |
| Guide RNA design | Proprietary in silico design; customer may provide approved guides |
| Off-target analysis | In silico prediction; optional targeted PCR validation |
| Delivery format | Glycerol stocks, lyophilized cultures, or agar slants as requested |
A streamlined process from project scoping to final strain delivery.
We discuss your target genes, strain background, and project-scoped attributes assessed analytically to define the knockout strategy and timeline.
Bioinformatics design of CRISPR guide RNAs targeting each gene, followed by construction of editing plasmids with Cas9 expression and guide cassettes.
Delivery of editing plasmids into B. subtilis competent cells, selection for editing events, and confirmation of knockout via colony PCR.
For multi-gene deletions, we repeat the transformation and selection process sequentially, verifying each knockout before proceeding.
Isolation of single colonies, purification of the final knockout strain, and comprehensive genotyping (PCR and Sanger sequencing) of all target loci.
From metabolic engineering to functional genomics.
Redirect metabolic flux by deleting competing pathways to evaluate target product yield.
Evaluate heterologous protein secretion by eliminating proteases or cell wall remodeling factors.
Study gene function by systematic knockout of gene clusters or operons.
Common inquiries about our multi-gene knockout service.
The number of target genes is scoped per project based on genetic context and project goals. We typically handle up to 3–5 sequential knockouts; larger sets can be discussed during consultation. Each round includes assessment, so overall timeline scales with gene count.
Success rates depend on factors such as target locus accessibility and strain background. We achieve reliable editing efficiencies through optimized transformation protocols and guide RNA design. Detailed efficiency data is provided in the project report, and acceptance criteria are defined in the SOW.
In silico off-target prediction is performed for each guide RNA. If requested, we can validate predicted off-target loci by targeted amplicon sequencing. No genome-wide off-target assay is performed as standard; this can be added per project scope.
We can work with common laboratory strains as well as industrial isolates. The transformation efficiency may vary; we will test competence and evaluate protocols for your strain. Please provide strain details during project scoping.
Get a customized quote for your Multi-Gene Knockout Strain Construction project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.